Lorcaserin CAS: 616202-92-7

• Post Date:

  Mar 06,2018

• Expiry Date:

  Mar 06,2019

• Detailed Description:

  Cas No. :616202-92-7 Quantity: 1Kilograms
  Specs:bodybuilding/ healthy care
  Price:1 USD Kilograms
  Payment Method: T/T Western union Moneygram
  CAS: 616202-92-7
  Synonym: Belviq, Apd 356, (1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
  MF: C11H14ClN
  MW：195.692
  Assay: 99%
  Quality Standards: USP
  Appearance: White to almost white crystalline powder
  Certification:ISO9001, ISO14000, KOSHER
  
  Indications and uses:
  Lorcaserin is a serotonin 2C receptor agonist suitable for chronic weight management as an aid in reducing calorie diet and increasing physical activity.
  For adults who have an initial body mass index (BMI):
  (1) 30kg / m2 or more (obesity).
  (2) At least one weight related comorbidity (eg, hypertension, dyslipidemia, type 2 diabetes) is present at 27 kg / m2 or greater (overweight).
  
  Limitations of use:
  (1) The safety and efficacy of co-administration with other weight loss products have not been established.
  (2) The impact of Lorcaserin on cardiovascular morbidity and mortality has not been established.
  
  Dosage and method of administration
  (1) 2 tablets a day 10mg.
  (2) Terminate if weight loss does not reach 5% at week
  
  Description:
  Lorcaserin, currently marketed under the trade name Belviq[2][3] and previously Lorqess during development,[4][5] is a weight-loss drug developed by Arena Pharmaceuticals. It reduces appetite by activating a type of serotonin receptor known as the 5-HT2C receptor in a region of the brain called the hypothalamus, which is known to control appetite.
  

• CAS Registry Number:

  616202-92-7

• Company:

  Wuhan Hezhong Bio-Chemical Manufature Co.,Ltd     [ China ]        

• Contact:

  Laura

• Tel:

  18872220713

• Fax:

  86-27-88048077

• Email:

  uoyyphar@ycphar.com